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Abstract 
Background 
Although definitive long-term results are not yet available, the global safety of laparoscopic 
surgery for rectal cancer treatment remains controversial. We evaluated differences in the 
safety of laparoscopic rectal resection versus open surgery for cancer. 
Methods 
A systematic review from 2000 to 2011 was performed searching the Medline and Embase 
databases (prospero registration CRD42012002406). We included randomized and 
prospective controlled clinical studies comparing laparoscopic and open resection for 
rectal cancer. Primary end points were 30-day mortality and overall morbidity. Then a 
meta-analysis was conducted by a fixed-effect model, performing a sensitivity analysis by 
a random-effect model. Relative risk (RR) was used as an indicator of treatment effect; a 
RR of less than 1.0 was in favor of laparoscopy. Publication bias was assessed by funnel 
plot and heterogeneity by the I 2 test and subgroup analysis on surgical and medical 
complications. 
Results 
Twenty-three studies, representing 4,539 patients, met the inclusion criteria; eight were 
randomized for a total of 1,746 patients. Mortality was observed in 1.0 % of patients in the 
laparoscopic group and in 2.4 % of patients in the open group. The overall RR was 0.46 
(95 % confidence interval 0.21–0.99, p = 0.048). The raw incidence of overall 
complications was lower in the laparoscopic group (31.8 %) compared to the open group 
(35.4 %). The overall RR was 0.83 (95 % confidence interval 0.76–0.91, p < 0.001). 
Conclusions 
On the basis of evidence of both randomized and prospective controlled series, mortality 
and morbidity RR, including subgroup analysis, were significantly lower after laparoscopic 
compared to open surgery. 
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Although laparoscopic resection of colon cancer is recently gaining acceptance [1-4], the 
role of laparoscopy in the treatment of rectal cancer is still controversial. 
Excellence of surgical technique is of particular relevance in the treatment of rectal cancer. 
Routine excision of the intact mesorectum during resection of cancers of the middle and 
lower rectum has resulted in a consistent reduction of local recurrences [5] and in an 
increase of long-term survival rates [6]. At present, open surgery is considered the 
treatment of choice for elective rectal resection in malignant diseases. Nevertheless, 
different reports have been presented in the literature during the past 10 years showing 
the feasibility of laparoscopic total mesorectal excision (TME) in expert centers. Although 
still lacking long-term oncological results, these studies have reported on postoperative 
course and short-term results. Some of them have advocated advantages of laparoscopy 
compared to open surgery for rectal cancer in terms of less pain, better postoperative 
pulmonary function, shorter postoperative ileus, shorter hospital stay, less fatigue, and 
better quality of life [7,8]. 
Whereas randomized, controlled trials (RCT) to evaluate recurrence rates and long-term 
survival of patients undergoing laparoscopic or open resection of rectal carcinoma will 
require a large number of patients and a long follow-up [9], clinically important short-term 
benefits of the minimal-access approach may be identified by analyzing the existing 
literature. The analysis of the short-term benefits of laparoscopy should be a prerequisite 
for the analysis of long-term results. 
The aim of this study was to evaluate in a meta-analysis whether there are clinically 
relevant short-term advantages of either laparoscopy or laparotomy for surgical treatment 
of rectal cancer in the published literature. 
 
 Materials and methods 
The methods for the analysis and generation of inclusion criteria were based on the 
recommendations of the Preferred Reporting Items for Systematic reviews and Meta-
Analysis (PRISMA) statement [10]. According to population, interventions, comparators, 
outcome measures, and setting criteria, patients were included if they had rectal cancer for 
which laparoscopic or laparotomic treatment was indicated. The study methods were 
documented in a protocol registered and accessible at http://www.crd.york.ac.uk/prospero/ 
(registration CRD42012002406). 
Types of studies 
Only RCTs or prospective controlled clinical trials were considered for this analysis, as 
suggested by the MOOSE group [11]. Studies were excluded if the study population 
included colon cancers, unless the data were presented separately. When multiple studies 
from the same institution were identified, the most recent or the most informative was 
selected. All and only full-text articles written in the English language were considered. 
Types of participants 
This meta-analysis compares laparoscopic and laparotomic resection for rectal cancer with 
regard to possible benefits of laparoscopy or laparotomy in the short-term postoperative 
period, defined as up to 30 days after surgery. 
Types of intervention 
All surgical procedures involving resection of the rectum were considered, including rectal 
anterior resection, coloanal anastomosis, Hartmann resection, and abdominoperineal 
resection. The type of interventions performed were noted in order to analyze separately 
those involving bowel anastomosis. For the laparoscopic group, any rectal resection 
performed through a mini-invasive approach (i.e., in a space generated by an insufflated 
pneumoperitoneum with the operative field visualization obtained by a video laparoscope 
and performed only through laparoscopic trocars) was included, while for open surgery, all 
procedures described as “open” or “conventional” and performed through an abdominal 
laparotomic incision were considered. 
Types of outcome measures 
Primary end points were overall mortality and morbidity at 30 days after surgery. 
Intraoperative and early (<30 days) postoperative complications directly related to surgery, 
and early (<30 days) postoperative medical complications were the objects of different 
sensitivity analyses. Anastomotic leakage, bleeding and blood loss, wound infection and/or 
wound dehiscence, pelvic and/or abdominal abscesses, and bowel and/or vascular and/or 
urological injuries were classified as surgical complications. Paralytic ileum and/or 
nonsurgical bowel obstruction, respiratory events, cardiovascular events, deep venous 
thrombosis and/or pulmonary embolism, urinary infection, urinary retention, nonsurgical 
infections, and sepsis were classified as medical complications. 
The secondary outcome measures were incidence of anastomotic leakage, abscesses, 
blood loss, time to first bowel movement, time for intake recovery, need for transfusion, 
length of hospital stay, wound infections, injuries to internal organs, need for 
reintervention, and operating time. 
Search strategy and data collection 
We searched the Medline and Embase databases for articles published from January 
2000 to December 2011. The search strategy was performed using the following terms: 
(rect* OR colorect*) AND (neoplas* OR adenocarcinoma OR carcinoma OR cancer) AND 
(laparoscop* OR (minima* AND invasive AND surgery) OR therapy) AND (anterior OR 
abdominoperineal AND resection OR proctectomy) OR (total AND mesorectal AND 
excision) AND [2000–2011]/py AND [humans]/lim. The literature search was closed on 
December 31, 2011. 
All abstracts retrieved from the electronic databases were screened independently by two 
authors (AA and GS); when an abstract was deemed relevant by at least one of them, the 
full text was retrieved. The reference lists of all relevant articles were manually searched 
for potentially relevant studies for inclusion. 
Data extraction was carried out in duplicate independently by two authors (AA and GS). 
Disagreements were resolved by discussion with a third author (MM). Data collection was 
carried out using a self-developed spreadsheet in Excel format. The following data were 
collected when available: study features, patients’ characteristics (gender, age, body mass 
index, American Society of Anesthesiology classification score, cancer localization and 
stage, neoadjuvant therapy, type of procedures performed), data needed for study quality 
assessment, and outcome measures. 
Assessment of risk of bias 
All studies meeting the selection criteria were assessed for methodological quality 
according to the Cochrane collaboration guidelines [12] for RCTs and to the Newcastle–
Ottawa scale for prospective controlled clinical trials [13]. This judgement was performed 
by three reviewers (AA, GS, and MV); disagreements were resolved by discussion and 
consensus. 
Statistical analysis 
All analyses were performed according to original treatment allocation (intention-to-treat 
analysis). For binary outcome data, the relative risks (RR) and 95 % confidence intervals 
(CI) were estimated by the Mantel–Haenszel method; a RR < 1 was in favor of 
laparoscopy. For continuous outcome data, the mean difference (MD) and 95 % CIs were 
estimated by the inverse variance weighting. A negative MD value was in favor of 
laparoscopy. When means and/or standard deviations were not reported in the original 
article, they were estimated from reported medians, ranges, and sample size as described 
by Hozo et al. [14]. 
A fixed-effects model was used in all meta-analyses, with the same analyses always 
redone by a random-effects model as described by DerSimonian and Laird [15]. 
Publication bias was assessed, generating a funnel plot, and we performed a rank 
correlation test of funnel plot asymmetry. Heterogeneity was assessed by the I 2 measure 
of inconsistency, considered statistically significant if I 2 was >50 %; whenever I 2 
was <50 %, the fixed-effects model was used. Otherwise the random-effects model was 
preferred. 
Potential sources of heterogeneity were explored by different sensitivity analyses: 
comparing fixed- versus random-effects models (thus incorporating heterogeneity by using 
the second method), performing subgroup analyses (always comparing RCTs versus 
prospective controlled clinical observational studies), checking the results of cumulative 
(sequentially including studies by date of publication), and influence meta-analyses 
(calculating pooled estimates, omitting one study at a time). All analyses were conducted 
by the R 2.15.0 software package meta [16]. 
Results 
Study selection 
The search retrieved 4,613 studies. Figure 1 illustrates the PRISMA flow chart for study 
inclusion and exclusion criteria. 
 
Fig. 1  
Flow chart detailing the article selection process 
Characteristics of included studies 
The characteristics of the 23 studies meeting the inclusion criteria are summarized in 
Table1 [2,17-38]. All 23 studies were reported as full articles and included a total of 4,539 
patients; eight were RCTs for a total of 1,746 patients, and 15 were prospective controlled 
clinical trials for a total of 2,793 patients. Guillou et al. [2] included patients affected by 
colorectal carcinoma; only data referring to rectal cases were collected for our meta-
analysis. 
Table 1  
Summary of studies included in the meta-analysis 
Gender (M/F) Age (mean ± SD) BMI (mean ± SD) 
Study 
Country 
and study 
period 
Inclusion 
criteria 
Exclusion 
criteriaa  
Eligible 
patients 
Lap 
surgery 
patients 
Open 
surgery 
patients Lap Open Lap Open Lap Open 
Conversion 
rate (%) 
Prospective controlled clinical trials 
 Leung et 
al. [29] 
Hong-Kong, 
Jan 1993–
Low rectal 
cancer 
2, 11 59 25 34 15/10 21/13 62.2 ± 13.3 63.5 ± 15.2 NA NA 8.0 
Gender (M/F) Age (mean ± SD) BMI (mean ± SD) 
Study 
Country 
and study 
period 
Inclusion 
criteria 
Exclusion 
criteriaa  
Eligible 
patients 
Lap 
surgery 
patients 
Open 
surgery 
patients Lap Open Lap Open Lap Open 
Conversion 
rate (%) 
Jan 1996 
 Anthuber 
et al. [30] 
Germany, 
Jan 1996–
March 2002 
Primary rectal 
cancer 
2, 4, 7, 9, 
12 435 101 334 59/42 236/98 61.6 ± 11.1 61.7 ± 11.0 26.9 ± 3.6 26.2 ± 4.2 10.9 
 Hu et al. 
[28] 
China, Oct 
2001–July 
2002 
Rectal 
cancer <15 cm 
from AV 
2, 3, 4, 5, 
9, 13, 14, 
16, 19, 20 
45 20 25 9/11 16/9 61.6 ± 8.4 58.0 ± 10.7 NA NA 0 
 Wu et al. 
[18] 
China, Apr 
2002–May 
2003 
NA 2, 9, 19 36 18 18 9/9 10/8 52.4 ± 7.9 54.1 ± 6.8 NA NA 0 
 Breukink 
et al. [19] 
Netherlands, 
Lap: Oct 
2000–
March 
2003; open: 
Apr 1996–
Nov 2001 
Primary rectal 
cancer after 
preoperative 
radiotherapy 
9, 19 82 41 41 25/16 23/18 68b  70b  25b  25b  9.8 
 Morino et 
al. [25] 
Italy, Apr 
1994–Apr 
2002 
Rectal 
cancer ≤12 cm 
from AV 
2, 9, 12, 
19 191 98 93 59/39 57/36 64.9 61.4 NA NA 18.4 
 Law et al. 
[31] 
Hong-Kong, 
June 2000–
Dec 2004 
Rectal cancer 
8–20 cm from 
AV 
2, 15 265 98 167 68/30 112/55 69b  70b  NA NA 12.2 
 Lelong et 
al. [33] 
France, Lap: 
Jan 2002–
Oct 2004; 
open: Jan 
1998–Dec 
2000 
Primary rectal 
cancer ≤15 cm 
from AV 
2, 9, 14, 
16 172 104 68 NA NA NA NA NA NA 14.4 
 Staudacher 
et al. [37] 
Italy, Jan 
1998–Sept 
2005 
Middle and 
low rectal 
cancer 
2 187 108 79 65/43 42/37 63.9 ± 12.2 64.7 ± 13.0 26.3 ± 3.8 25.8 ± 4.1 12.0 
 Veenhof et 
al. [21] 
Netherlands, 
Lap: Apr 
2002–Nov 
2005; open: 
Feb 1999–
Apr 2002 
Rectal 
cancer ≤17 cm 
from AV 
20 100 50 50 28/22 32/18 67b  64.5b  25b  26b  8.0 
 Ströhlein 
et al. [35] 
Germany, 
1998–2005 
Rectal 
cancer ≤16 cm 
from AV 
NA 389 114 275 72/42 163/112 65.0 ± 9.9 65.5 ± 11.3 NA NA 21.9 
 Koulas et 
al. [26] 
Greece, Oct 
1998–Dec 
2006 
Rectal 
cancer ≤17 cm 
from AV 
1, 4, 9, 
11, 14, 
15, 16, 
18, 20 
117 57 60 33/24 35/25 63.8 ± 12.7 68.9 ± 12.6 23.0 25.0 7.0 
 Laurent et 
al. [24] 
France, Lap: 
2000–2006 
Open: 
1994–1996 
Rectal 
cancer ≤15 cm 
from AV 
4, 6, 9, 
12, 15, 16 471 238 233 140/98 156/77 66.0 67.3 24.0 25.0 15.1 
 Khaikin et 
al. [22] 
USA, Nov 
2004–July 
2006 
Rectal 
cancer ≤15 cm 
from AV 
6, 7, 9, 16 82 32 50 13/19 30/20 56.3 63.7 25.3 29.1 12.5 
 Baik et al. 
et al. [38] USA 
Rectal 
cancer ≤12 cm 
from AV 
4, 5, 6, 9, 
14 162 54 108 37/17 62/46 60.0 ± 12.7 60.6 ± 13.6 27.3 ± 4.2 28.9 ± 5.2 11.1 
  
Sept 2001–
Sept 2005                         
Randomized controlled trials 
 Zhou et al. 
[17] 
China, June 
2001–Sept 
2002 
Rectal cancer 
with lowest 
margin under 
the peritoneal 
reflection and 
1.5 cm above 
the dentate 
1, 2, 8, 9, 
11 171 82 89 46/36 43/46 44.0 45.0 NA NA NA 
Gender (M/F) Age (mean ± SD) BMI (mean ± SD) 
Study 
Country 
and study 
period 
Inclusion 
criteria 
Exclusion 
criteriaa  
Eligible 
patients 
Lap 
surgery 
patients 
Open 
surgery 
patients Lap Open Lap Open Lap Open 
Conversion 
rate (%) 
line 
Guillou et 
al. [2] 
UK, July 
1996–July 
2002 
Cancer of the 
colon and 
rectum 
2, 3, 4, 5, 
6 381 253 128 NA NA NA NA NA NA 32.4 
González 
et al. [32] 
Spain, Jan 
2003–April 
2004 
Rectal 
cancer <15 cm 
from AV 
2, 9, 10, 
12 40 20 20 11/9 8/12 66.6 ± 12.6 70.7 ± 9.2 26.0 ± 2.9 27.9 ± 5.1 10.0 
Braga et al. 
[34] 
Italy, not 
reported Rectal cancer 
2, 9, 13, 
14, 17 168 83 85 55/28 64/21 62.8 ± 12.6 65.3 ± 10.3 NA NA 7.2 
Ng et al. 
[36] 
Hong-Kong, 
July 1994–
Feb 2005 
Rectal 
cancer ≤5 cm 
from AV 
2, 7, 9, 
10, 11 99 51 48 31/20 30/18 63.7 ± 11.8 63.5 ± 12.6 NA NA 9.8 
Lujan et al. 
[25] 
Spain, Jan 
2002–Feb 
2007 
Mid and low 
rectal cancer 2, 9, 15 204 101 103 62/39 64/39 67.8 ± 12.9 66.0 ± 9.9 NA NA 7.9 
Kang et al. 
[27] 
South 
Korea, Apr 
2006–Aug 
2009 
Rectal 
cancer ≤9 cm 
from AV 
2, 4, 5, 9, 
14, 16 340 170 170 110/60 110/60 57.8 ± 11.1 59.1 ± 9.9 24.1 ± 3.2 24.1 ± 3.2 1.2 
Liang et al. 
[23] 
China, May 
2004–Apr 
2008 
Rectal cancer 
2, 11, 16, 
17, 18, 
19, 20 
343 169 174 104/65 92/82 57.3b  57.4b  21.5b  22.3b  0.6 
AV anal verge, Lap laparoscopic, BMI body mass index, NA not available 
aExclusion criteria are as follows: 1 = neoplasm other than adenocarcinoma (e.g., 
lymphoma); 2 = emergency situations (e.g., acute obstruction, hemorrhage, perforation); 
3 = contraindications to pneumoperitoneum; 4 = malignant diseases in the past 5 years or 
synchronous adenocarcinoma; 5 = pregnancy; 6 = associated gastrointestinal diseases 
needing surgical intervention; 7 = recurrent disease; 8 = lowest margin of tumor within 
1.5 cm above the dentate line; 9 = Dukes stage D or T4 TNM stage; 10 = tumor larger than 
6 cm; 11 = patients unwilling to take part in the study; 12 = local surgery candidates; 
13 = age < 18 or > 80 years; 14 = respiratory dysfunction, cardiovascular dysfunction, 
hepatic dysfunction, American society of anesthesiology IV; 15 = familial adenomatous 
polyposis; 16 = presence of metastases; 17 = ongoing infections, low plasma neutrophil 
levels; 18 = BMI > 30 kg/m²; 19 = previous colon or rectal surgery and/or previous 
neoadiuvant chemotherapy; 20 = previous abdominal surgery 
bMedian value 
Table 2 lists baseline patient characteristics comparing open and laparoscopic procedures. 
Table 3 lists characteristics of tumor location and stage, adjuvant therapy, and percentage 
of protective ileostomy. 
 
 
Table 2  
Comparison of baseline patient characteristics 
No. of patients Gender (M/F)a  Mean age (years) Mean BMI (kg/m2) RCT 
Lap Open Lap Open Lap Open Lap Open 
No 1,158 1,635 632/422 995/572 63.6 63.8 25.2 26.3 
Yes 929 817 419/257 411/278 59.3 59.9 24.3 24.5 
Overall 2,087 2,452 1,051/679 1,406/850 62.0 62.7 25.0 25.9 
RCT randomized controlled trial, Lap laparoscopic, BMI body mass index 
aThe number of male and female subjects are not equal to the total number because 
gender data were not available in two studies (Guillou et al. [2] and Lelong et al. [33) 
Table 3  
Comparison of tumor location, cancer stage, neoadjuvant therapy, and protective 
ileostomy 
No. of 
patients 
Mean distance from anal 
verge (cm) 
Tumor stage, T0–
T2a  
Tumor stage, T3–
T4a  
Neoadjuvant 
therapy 
Protective 
ileostomyb  RCT 
Lap Open Lap Open Lap Open Lap Open Lap Open Lap Open 
No 1,158 1,635 7.22 6.35 520/852 670/1,240 332/852 570/1,240 538/842 720/1,405 553/968 774/1,308 
Yes 929 817 6.50 6.47 175/342 153/341 167/342 188/341 267/425 268/426 208/400 200/406 
Overall 2,087 2,452 6.75 6.43 695/1,194 823/1,581 499/1,194 758/1,581 805/1,267 988/1,831 761/1,368 974/1,714 
RCT randomized controlled trial, Lap laparoscopic 
aTumor stage numbers are not equal to the total number because data were not available 
in all studies 
bPercentages of protective ileostomy are calculated, when available, from the number of 
patients undergoing a surgical procedure involving a bowel anastomosis 
Risk of bias of included studies 
Assessment of quality according to the Cochrane collaboration’s tool for assessing risk of 
bias for RCTs and to the Newcastle–Ottawa scale for prospective controlled clinical trials 
are presented in Tables 4 and 5, respectively. 
Table 4  
Quality assessment of the included randomized controlled studies based on the Cochrane 
collaboration’s tool for assessing the risk of bias 
Study 
Random 
sequence 
generation 
Allocation 
concealment 
Blinding of 
participants, 
personnel and 
outcome 
Incomplete 
outcome 
data 
Selective 
outcome 
reporting 
Other 
source 
of bias 
Study 
Random 
sequence 
generation 
Allocation 
concealment 
Blinding of 
participants, 
personnel and 
outcome 
Incomplete 
outcome 
data 
Selective 
outcome 
reporting 
Other 
source 
of bias 
Zhou et 
al. [17] No No Unclear Unclear No Yes 
Guillou et 
al. [2] Unclear Yes
a  Unclear Unclear Unclear Yes 
González 
et al. [32] Unclear Unclear Unclear Unclear No Yes 
Braga et 
al. [34] Yes
b  Yesa  Unclear Yes Yes Yes 
Ng et al. 
[36] Yes
b  Yesa  Unclear Yes Yes Yes 
Lujan et 
al. [25] Yes
b  Yesa  Unclear Yes Yes Yes 
Kang et 
al. [27] Yes
b  Yesa  Yesc  Yes Yes Yes 
Liang et 
al. [23] Unclear Yes
a  Yesc  Yes Yes Yes 
In all cases, “yes” indicates a low risk of bias, “no” indicates high risk of bias, and “unclear” 
indicates unclear or unknown risk of bias 
aIn Guillou et al. [2] and Kang et al. [27], allocation concealment was done by telephone by 
the trial coordinator; in Braga et al. [34], Lujan et al. [25], and Liang et al. [23] by means of 
sealed envelopes; in and Ng et al. [36] by an independent operating theater coordinator 
bIn Braga et al. [34], Ng et al. [36], Lujan et al. [25], and Kang et al. [27], the randomization 
sequence was generated by a computer program 
cIn Kang et al. [27], pathologists who examined the resected specimen were masked to 
patients’ allocation; in Liang et al. [23], patients were assessed for postoperative 
complications by a reviewer unaware of patients’ allocation 
Table 5  
Quality assessment of the included prospective controlled clinical trials based on the 
Newcastle–Ottawa scale 
Selectiona Comparabilityb Outcome assessmentc Study 
1 2 3 4 5 6 7 
Score 
Leung et al. [29] *     * **   * 5 
Anthuber et al. [30] * * * * * * * 7 
Hu et al. [28] * * * * ** * * 8 
Wu et al. [18] * * * ** ** *   8 
Breukink et al. [19] * * * * ** * * 8 
Morino et al. [25] * * * ** * * * 8 
Law et al. [31] * * * **   * * 7 
Lelong et al. [33] * * * ** * * * 8 
Staudacher et al. [37] * * * ** ** * * 9 
Veenhof et al. [21] * * * * ** *   7 
Ströhlein et al. [35] * * * * ** * * 8 
Koulas et al. [26] * * *     * * 5 
Laurent et al. [24] * * *     *   4 
Khaikin et al. [22] * * *     *   4 
Baik et al. [38] * * * ** ** * * 9 
aSelection: (1) assignment for treatment (if yes, one point). (2) How representative was the 
laparoscopic group in comparison to the general population undergoing rectal resections 
(if yes, one point; no points if the patients were selected or selection of group was not 
described). (3) How representative was the open group in comparison to the general 
population undergoing rectal resections (if yes, one point; no points if the patients were 
selected or selection of group was not described) 
bComparability: (4) group comparable for 1–3 (if yes, two points; one point if one of these 
three characteristics was not reported even if there were no other differences between the 
two groups and other characteristics had been controlled for; no points were assigned if 
the two groups differed). (5) Group comparable for 4–7 (if yes, two points; one point if one 
of these four characteristics was not reported even if there were no other differences 
between the two groups and other characteristics had been controlled for; no points were 
assigned if the two groups differed). Comparability variables: 1 = age, 2 = gender, 
3 = American Society of Anesthesiology score, 4 = neoadjuvant/adjuvant therapy, 
5 = tumor location, 6 = stage, 7 = procedure 
cOutcome assessment: (6) clearly defined outcome of interest (if yes, one point for 
information ascertained by medical records or interview; no points if this information was 
not reported). (7) Follow-up equal between the two groups (if yes, one point; no points if 
follow-up not reported) 
Figure 2 reports the potential sources of heterogeneity within all studies by a L’Abbé plot 
for morbidity outcome. 
 
Fig. 2  
L’Abbé plot for morbidity outcome for all trials to investigate potential sources of 
heterogeneity; the event rate in the laparoscopy group is plotted on the vertical axis and 
that in the open group on the horizontal one; circle dimension is proportional to the number 
of patients enrolled; the solid line is the overall RR line, representing the RR estimation by 
pooling the results of all studies. RR relative risk 
Primary outcomes 
The meta-analyses on the two primary outcomes investigated mortality and overall 
complications. For the first outcome, the raw incidence of mortality was lower in the 
laparoscopic group (1.0 %) compared to the open group I 2 0.4 %). The overall RR was 
0.46 (95 % confidence interval [CI] 0.21–0.99, p = 0.048), showing no differences between 
the RCT and prospective controlled clinical trial subgroups (RR 0.80 vs. 0.36, p = 0.327) 
(Fig. 3). No publication bias was found by the rank correlation test of funnel plot 
asymmetry (p = 0.579). When we performed a cumulative meta-analysis with these ten 
studies (three RCTs and seven prospective trials), adding one study at a time by 
publication date, the RR varied from 0.33 to 0.54; when we performed an influential meta-
analysis by omitting one study in turn, the RR ranged from 0.42 to 0.55 for the entire time 
frame. 
 
Fig. 3  
Forest plot for 30-day mortality. RR relative risk, 95 % CI confidence interval, W weight of 
the single study 
For the second outcome, the raw incidence of overall complications was lower in the 
laparoscopic group (31.8 %) compared to the open group (35.4 %). The overall RR was 
0.83 (95 % CI 0.76–0.91, p < 0.001), with a statistically significant difference favoring 
prospective controlled clinical trials (RR 0.94 vs. 0.76, p = 0.021) (Fig. 4). Once again, no 
publication bias was found (p = 0.450). When we performed a cumulative meta-analysis 
with these 22 studies (eight RCTs and 14 prospective trials), the RR varied from 0.25 to 
0.98, ranging only from 0.81 to 0.84 in the last period, 2007–2011; the main heterogeneity 
source was represented by the study by Guillou et al. [2]. In the influential meta-analysis 
assessment, the RR that resulted was quite stable, ranging from 0.79 to 0.85 in the whole 
publication period and confirming the same trial as the cause of heterogeneity. 
 
Fig. 4  
Forest plot for 30-day overall morbidity. RR relative risk, 95 % CI confidence interval, W 
weight of the single study 
Secondary outcomes 
As secondary outcomes, the meta-analysis investigated medical and surgical 
complications in detail, such as number of patients with at least one medical or surgical 
complication, duration of surgery, mean blood loss, incidence injuries, bowel movement 
recovery, food intake recovery, blood transfusions, incidence of abscesses, incidence of 
wound complications, incidence of anastomotic leakages, incidence of reintervention, and 
length of hospital stay. 
Percentages of patients with at least one medical or surgical complication was 31.9 % in 
the laparoscopic group and 35.4 % in the open surgery group; the overall RR was 0.83 
(95 % CI 0.76–0.91, p < 0.001), without differences between RCTs and prospective 
controlled clinical trials (RR 0.94 vs. 0.76, p = 0.021). 
The surgical complication rate was 16.6 % in the laparoscopic group and 19.0 % in the 
open group; the overall RR was 0.78 (95 % CI 0.68–0.89, p < 0.001) (Fig. 5), with no 
differences between subgroups (RR 0.84 vs. 0.74, p = 0.361). 
 
Fig. 5  
Forest plot for 30-day surgical complications. RR relative risk, 95 % CI confidence interval, 
W weight of the single study 
All but one study [17] provided the rate of conversion to open surgery. Overall, 13.0 % 
(260 of 2,005) laparoscopic cases were converted to laparotomy, 12.5 % (106 of 847) in 
the RCT studies and 13.3 % (154 of 1,158) in the prospective controlled clinical trials. 
Conversion rate ranged between 0.6 % [23] and 32.4 % [2] among RCT studies, and 
between 0 % [18,28] and 21.9 % [35] in the prospective trials. Among RCT studies, 
reported conversion rates showed a strong time trend; this was not the case in the 
prospective trials (Table 1). 
Medical complications rate was 16.6 % in the laparoscopic group and 19.1 % in the open 
group; the overall RR was 0.89 (95 % CI 0.78–1.02, p = 0.101) (Fig. 6), with a slight 
difference in the subgroup analysis (RR 1.06 vs. 0.79, p = 0.044). 
 
Fig. 6  
Forest plot for 30-day medical complications. RR relative risk, 95 % CI confidence interval, 
W weight of the single study 
The mean operative time was 219 min for laparoscopic surgery and 175 min for open 
surgery; the overall MD was 42.8 min (95 % CI 31.4–54.2, p < 0.001) (Fig. 7). Prospective 
trials had a significantly shorter duration (MD 30.0 vs. 52.0, p = 0.040), but with an 
extreme heterogeneity (I 2 92.9 %). 
 
Fig. 7  
Forest plot for mean operative time. MD mean difference, 95 % CI confidence interval, W 
weight of the single study 
The mean blood loss was 307 ml in the laparoscopic group and 444 ml in the open 
surgery; the overall MD was −137 ml (95 % CI −199 to −75, p < 0.001) (Fig. 8), without 
subgroup differences (MD −103 vs. −146, p = 0.360) but with extreme heterogeneity (I 2 
95.6 %). 
 
Fig. 8  
Forest plot for mean blood loss. MD mean difference, 95 % CI confidence interval, W 
weight of the single study 
The raw incidence of intraoperative injuries was 2.5 % among laparoscopic patients and 
2.0 % among open patients; the overall RR was 1.11 (95 % CI 0.65–1.91, p = 0.701) (Fig. 
9), without differences between RCTs and prospective trials (RR 1.36 vs. 0.93 p = 0.484). 
 
Fig. 9  
Forest plot for incidence of intraoperative injuries. RR relative risk, 95 % CI confidence 
interval, W weight of the single study 
The mean time for bowel movement recovery was 3.3 days in the laparoscopic group and 
4.4 days in the open one; the overall MD was −0.96 days (95 % CI −1.3 to −0.6, p < 0.001) 
(Fig. 10), once again without differences between RCT and prospective controlled clinical 
trials (MD −0.94 vs. −1.04, p = 0.815), but with very high heterogeneity (I 2 81.4 %). 
 
Fig. 10  
Forest plot for bowel movement recovery. MD mean difference, 95 % CI confidence 
interval, W weight of the single study 
The food intake recovery occurred after a mean of 3.8 days in the laparoscopic group and 
4.8 days for the open surgery group; the overall MD was −1.0 days (95 % CI −1.4 to −0.7, 
p < 0.001) (Fig. 11), with no RCT versus prospective trials differences (MD −1.0 vs. −1.1, 
p = 0.651), and with very high heterogeneity (I 2 75.4 %). 
 
Fig. 11  
Forest plot for food intake recovery. MD mean difference, 95 % CI confidence interval, W 
weight of the single study 
Blood transfusions were needed by 5.1 % of laparoscopic and 16.6 % of open patients; the 
overall RR was 0.34 (95 % CI 0.24 to 0.49, p < 0.001) (Fig. 12), with no subgroup 
differences (RR 0.30 vs. 0.40, p = 0.451) and moderate heterogeneity (I 2 28.9 %). 
 
Fig. 12  
Forest plot for incidence of blood transfusion. RR relative risk, 95 % CI confidence interval, 
W weight of the single study 
Abscesses were observed in 2.7 % of patients in the laparoscopic group and 1.8 % of 
patients in the open group; the overall RR was 1.04 (95 % CI 0.66–1.63, p = 0.862) (Fig. 
13), with no subgroup differences (RR 1.01 vs. 1.05, p = 0.943). 
 
Fig. 13  
Forest plot for incidence of abdominal abscesses. RR relative risk, 95 % CI confidence 
interval, W weight of the single study 
On the other hand, wound complications were reported for 5.9 % laparoscopic patients 
and 8.1 % open patients; the overall RR was 0.66 (95 % CI 0.52–0.83, p < 0.001) 
(Fig. 14), with no subgroup differences (RR 0.58 vs. 0.74, p = 0.285). 
 
Fig. 14  
Forest plot for incidence of wound complications. RR relative risk, 95 % CI confidence 
interval, W weight of the single study 
Incidence of anastomotic leakage occurred in 7.6 % laparoscopic patients and 8.9 % open 
patients. The overall RR was 0.83 (95 % CI 0.65–1.06, p = 0.128) (Fig. 15), without 
differences between RCTs and prospective trials (RR 0.92 vs. 0.79, p = 0.556). 
 
Fig. 15  
Forest plot for incidence of anastomotic leakage. RR relative risk, 95 % CI confidence 
interval, W weight of the single study 
The ratio of patients who needed a surgical reintervention within the first 30 postoperative 
days was 6.3 % for laparoscopic cases and 7.4 % for open cases; the overall RR was 0.84 
(95 % CI 0.57–1.22, p = 0.357) (Fig. 16), again without RCT versus prospective trial 
differences (RR 0.72 vs. 0.89, p = 0.617). 
 
Fig. 16  
Forest plot for incidence of reintervention. RR relative risk, 95 % CI confidence interval, W 
weight of the single study 
The mean duration for hospital stay was 10.8 days in the laparoscopic group and 
13.5 days for the open surgery group; the overall MD was −2.7 days (95 % CI −3.6 to 
−1.7, p < 0.001) (Fig. 17), with no differences in the subgroup analysis (MD −3.5 vs. −2.4, 
p = 0.320), and again with very high heterogeneity (I 2 77.4 %). 
 
Fig. 17  
Forest plot for length of hospital stay. MD mean difference, 95 % CI confidence interval, W 
weight of the single study 
Discussion 
Almost 20 years after the first report of laparoscopic colorectal surgery [39], laparoscopy 
has diffused widely to many fields, but its use in the treatment of colorectal diseases is still 
debated. Especially in the field of rectal surgery, where TME and systematic 
lymphadenectomy are considered the main step of curative therapy for rectal cancer [5], 
until now, available data have not permitted us to come to any reliable conclusions. 
Although long-term survival studies are awaited to focus on the oncologic adequacy of 
laparoscopic treatment of rectal cancer, a short-term analysis of safety can be performed 
on existing data. 
Since 2000, a total of 23 studies [2,17-38] have been published comparing laparoscopic 
and open rectal resection in terms of safety. Although a meta-analysis of only RCTs would 
be ideal, we thought it wiser to extend the inclusion criteria to prospective nonrandomized 
matched series in order to increase the data to analyze while maintaining an acceptable 
level of evidence, as confirmed by risk of bias analysis and heterogeneity test. An analysis 
of subgroups to verify the reliability of the RCT-only analysis was performed anyway. 
Because of these restrictions in the selections of articles, heterogeneity of results was kept 
reasonable, even though some of the study samples included in this analysis were 
relatively small and none of the included studies had made an estimate of what sample 
size was needed to detect differences between laparoscopic and open surgery on the 
basis of a well-defined primary outcome. The sensitivity analyses reveal that no study 
played an influential role on RR in the whole time frame studied, and that heterogeneity 
was reduced when including only articles published after 2005. This methodology has led 
to a more strict selection than the last Cochrane Review published on the topic [40], in 
which, as a result of lack of data, case series and case reports were also included, thus 
worsening reliability. 
Although the initial purpose was to restrict our analysis to TME and other abdominal 
resections with primary anastomosis for rectal cancer, the analysis of data present in 
literature showed a majority of reports including abdominoperineal resections. Because it 
was not possible to separate data between the two groups, we decided to extend the 
analysis to both treatments and redesigned the study protocol accordingly, after verifying 
that the procedure was equally represented, with no selection bias in both groups in each 
of the studies. This way, we also included two reports entirely focusing on 
abdominoperineal resections [29,36]. We conducted two separate analyses, one including 
and one excluding these reports, only to find that the results substantially overlapped, so 
we opted to include them into the analysis. Finally, we verified, when available, that the 
tumor location and stage of cancer disease, neoadjuvant chemoradiotherapy, and 
protective ileostomy rates were comparable in the global analysis. 
The main finding of the present meta-analysis was that the incidence of mortality showed a 
significant reduction in the laparoscopic group compared to open surgery. Furthermore, 
the overall incidence of postoperative complications was also significantly lower in the 
laparoscopic group, with a RR of 0.81. The analysis of all included studies showed a clear 
advantage for laparoscopy in the specific analysis of both surgical and medical 
complications. This was confirmed by the analysis of prospective controlled clinical trials, 
while the analysis of RCTs showed a significant advantage only for surgical complications. 
The most probable explanation of the lack of statistical significance in some of the 
analyses performed on RCT studies only is the insufficient number of patients randomized, 
which is about one third of the total number of patients compared. A further possible 
explanation might be the inclusion of the UK MRC CLASICC trial [2]. This has already 
been recently argued by other authors [41], who have underlined that even though this is 
the only multicenter RCT published on rectal cancer, the results are probably influenced by 
the surgeons’ short learning curve before entering the study. In fact, all the participating 
surgeons were required to have completed only 20 laparoscopic colorectal resections 
before entering the study. This could explain why in the initial phase the conversion rate 
was as high as 45 %, which declined to 15 % in the last year of the study. Different figures 
were reported when high-volume centers or single experience of highly trained and 
experienced colorectal surgeons were considered [20,24,37,42]. In fact, among all the 
studies analyzed, the CLASICC trial showed a clear discrepancy of results compared to 
the rest of the studies, although without affecting heterogeneity. Thus, the way in which 
these results will ultimately translate into common daily clinical practice remains unclear. 
Another important finding of the present analysis was that no statistically significant 
difference in anastomotic leakage rate was observed. This represents an original finding, 
as the concern for a possible increase in anastomotic leakage in the laparoscopic group 
had risen in the past years. The high incidence of leakage was explained with the difficult 
access of laparoscopic linear staplers to the distal rectum in a narrow pelvis, the oblique 
transection from right to left or from anterior to posterior depending on the trocar of 
insertion for the stapler, and the difficulty of cephalad traction on the rectum. In recent 
years, the advent of new technologies, such as ultrasonic scalpel and articulated stapler, 
and better surgical experience resulted in a progressive optimization of the technique that 
most probably is reflected in the equivalence of leakage rates and the lower incidence of 
surgical complications with the laparoscopic approach. 
Laparoscopy also confirmed, as it has already been demonstrated in the treatment of 
colon cancer [1-4], a clear advantage in terms of an earlier bowel activity restoration, time 
to oral intake, and duration of postoperative hospital stay, whereas the only clear 
disadvantages was the relatively longer operative time. 
Further analyses would have been of extreme interest, such as sexual and urinary 
dysfunction, postoperative quality of life, and R0 achievement, but the lack of sufficient 
data on these topics did not permit us to analyze these factors further. 
Nevertheless, the data analyzed in this meta-analysis suggest that laparoscopy has 
different clinical advantages in the perioperative period of rectal cancer surgery, in line with 
the well-described results of laparoscopic colon surgery [43]. Nevertheless, these results 
should be interpreted cautiously because our analysis has several limitations. First, most 
of the studies published were of relatively low quality according to acknowledged scientific 
criteria such as the Cochrane collaboration’s tool for assessing risk of bias scale and the 
Newcastle–Ottawa scale. Second, most of the studies did not have short-term 
complications as a primary outcome. Finally, scarce data regarding preoperative stage, 
patient selection, and neoadjuvant therapy were reported in the majority of the studies, so 
that a vast heterogeneity can be imagined among overall analyzed patients. 
Good-quality RCTs comparing short-term outcome of laparoscopic TME are greatly 
needed. Although we have seen the results of the 5-year follow-up of the CLASICC trial 
[44], which confirms the oncological safety of laparoscopic surgery for both colonic and 
rectal cancer, we will be awaiting the long-term oncological outcome of the COLOR II trial 
to reassert this statement [9]. 
Notwithstanding the above-mentioned limitations, we can conclude that on the basis of 
evidence of both randomized and prospective matched series, laparoscopic rectal 
resection appears to have clinically measurable short-term advantages in patients with 
primary resectable rectal cancer. Although technically demanding, laparoscopic rectal 
resection is safe and results in faster recovery. 
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